Search research articles
Contact Us
Filters
Showing results (291-300 of 381) with videos related to
Page
of 39
Sort By:
The American Journal of Pathology
|
November 12, 1998
Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridization
J Richter, L Beffa, U Wagner, et al.
Developmental Biology
|
July 27, 2011
miR-196 regulates axial patterning and pectoral appendage initiation
Xinjun He, Yi-Lin Yan, Johann K Eberhart, et al.
Molecular Endocrinology (Baltimore, Md.)
|
July 14, 2000
Bcl-x and Bax regulate mouse primordial germ cell survival and apoptosis during embryogenesis
E B Rucker, P Dierisseau, K U Wagner, et al.
The Journal of Rheumatology
|
May 1, 2001
Immunogenetic markers and seropositivity predict radiological progression in early rheumatoid arthritis independent of disease activity
S Kaltenhäuser, U Wagner, E Schuster, et al.
Journal of Cancer Research and Clinical Oncology
|
June 3, 2022
Quality assurance and improvement in oncology using guideline-derived quality indicators - results of gynaecological cancer centres certified by the German cancer society (DKG)
E Griesshammer, S Wesselmann, M W Beckmann, et al.
Genes and Function
|
July 25, 1998
Oxytocin and milk removal are required for post-partum mammary-gland development
K U Wagner, W S Young, X Liu, et al.
Neuroreport
|
November 14, 1997
Tau phosphorylation in transgenic mice expressing glycogen synthase kinase-3beta transgenes
J Brownlees, N G Irving, J P Brion, et al.
Oncogene
|
August 29, 2007
Disruption of cyclin D1 nuclear export and proteolysis accelerates mammary carcinogenesis
D I Lin, M D Lessie, A B Gladden, et al.
Development (Cambridge, England)
|
October 25, 2000
Conditional deletion of the Bcl-x gene from erythroid cells results in hemolytic anemia and profound splenomegaly
K U Wagner, E Claudio, E B Rucker, et al.
Geburtshilfe Und Frauenheilkunde
|
April 29, 2014
Statement by the Kommission OVAR of the AGO Study Group on the Use of HIPEC (Hyperthermic Intraperitoneal Chemotherapy) to Treat Primary and Recurrent Ovarian Cancer
P Harter, S Mahner, F Hilpert, et al.
Page
of 39
Search research articles
Search
Showing results (291-300 of 381) with videos related to
Sort By:
Page
of 39
The American Journal of Pathology
|
November 12, 1998
Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridization
J Richter, L Beffa, U Wagner, et al.
Developmental Biology
|
July 27, 2011
miR-196 regulates axial patterning and pectoral appendage initiation
Xinjun He, Yi-Lin Yan, Johann K Eberhart, et al.
Molecular Endocrinology (Baltimore, Md.)
|
July 14, 2000
Bcl-x and Bax regulate mouse primordial germ cell survival and apoptosis during embryogenesis
E B Rucker, P Dierisseau, K U Wagner, et al.
The Journal of Rheumatology
|
May 1, 2001
Immunogenetic markers and seropositivity predict radiological progression in early rheumatoid arthritis independent of disease activity
S Kaltenhäuser, U Wagner, E Schuster, et al.
Journal of Cancer Research and Clinical Oncology
|
June 3, 2022
Quality assurance and improvement in oncology using guideline-derived quality indicators - results of gynaecological cancer centres certified by the German cancer society (DKG)
E Griesshammer, S Wesselmann, M W Beckmann, et al.
Genes and Function
|
July 25, 1998
Oxytocin and milk removal are required for post-partum mammary-gland development
K U Wagner, W S Young, X Liu, et al.
Neuroreport
|
November 14, 1997
Tau phosphorylation in transgenic mice expressing glycogen synthase kinase-3beta transgenes
J Brownlees, N G Irving, J P Brion, et al.
Oncogene
|
August 29, 2007
Disruption of cyclin D1 nuclear export and proteolysis accelerates mammary carcinogenesis
D I Lin, M D Lessie, A B Gladden, et al.
Development (Cambridge, England)
|
October 25, 2000
Conditional deletion of the Bcl-x gene from erythroid cells results in hemolytic anemia and profound splenomegaly
K U Wagner, E Claudio, E B Rucker, et al.
Geburtshilfe Und Frauenheilkunde
|
April 29, 2014
Statement by the Kommission OVAR of the AGO Study Group on the Use of HIPEC (Hyperthermic Intraperitoneal Chemotherapy) to Treat Primary and Recurrent Ovarian Cancer
P Harter, S Mahner, F Hilpert, et al.
Page
of 39